How to develop an HME process for injectable drug delivery implants?

Subcutaneous implants are injectable drug delivery systems effective for treatments lasting weeks to years. These implants ensure the active pharmaceutical ingredient (API) is released precisely where needed, reducing dosage and side effects. Hot melt extrusion (HME) is the recommended technique for manufacturing injectable implants, ensuring a consistent dissolution rate and producing a homogeneous product with tight tolerances.

 

This webinar serves as an introduction to the subject, providing a comprehensive overview of potential materials (polymers) that can be utilized, various product designs, and existing marketed products within these drug delivery systems. Additionally, it elucidates the HME production process, highlighting critical considerations to ensure the highest quality product. Attendees will gain valuable insights into the design and manufacturing of injectable implants, and understand the innovations and best practices in this evolving field.

 

Learning Objectives